Description

Bavencio is a medication used in immunotherapy for the treatment of certain types of cancer, including metastatic Merkel cell carcinoma and urothelial carcinoma. It works by blocking the PD-1 pathway, enhancing the immune response against cancer cells.

Interpreter Notes

Interpreters should be aware that Bavencio may be referred to by its generic name, avelumab, in some contexts. It is important to maintain a formal register and avoid colloquial terms. Ensure clarity when discussing treatment options and potential side effects.

Example Sentences

EN: The oncologist prescribed Bavencio as part of the patient's cancer treatment plan.

ES: El oncólogo prescribió Bavencio como parte del plan de tratamiento del cáncer del paciente.

Common Interpreter Mistakes

Confusing Bavencio with other immunotherapy drugs; mispronouncing 'Bavencio' as 'Bavencio' but with incorrect emphasis; mixing up indications for use with other cancer treatments.